Kerrie B. Bouker

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

Kerrie B. Bouker, Todd C. Skaar, Rebecca B. Riggins et al. · Carcinogenesis · 2005 · 135 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).

Zhiping Gu, Richard Y. Lee, Todd C. Skaar et al. · PubMed · 2002 · 97 citations

Life Sciences, Cancer Biology, Molecular Biology +17

The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization

Jeremy W. Peck, Michael D. Oberst, Kerrie B. Bouker et al. · Journal of Biological Chemistry · 2002 · 96 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors

John L. Marshall, Huanwen Chen, Dongxiao Yang et al. · Annals of Oncology · 2004 · 72 citations · Full text

Medicine, Oncology, Pharmacology +14

Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant)

Kerrie B. Bouker, Todd C. Skaar, David Fernández et al. · Cancer Research · 2004 · 70 citations

Life Sciences, Cancer Biology, Oncology +17